Vasculogenesis is the de-novo formation of blood vessels from endothelial precursor cells, distinct from angiogenesis (sprouting from existing vessels) and arteriogenesis (enlargement of existing collateral arterioles). The three processes overlap in tissue-repair contexts and are sometimes pooled under the broader phrase neovascularisation.
Definition
Vasculogenesis describes the process by which new blood vessels form from endothelial precursor cells (also called angioblasts or endothelial progenitor cells). The precursor cells differentiate into mature endothelial cells, organise into nascent vascular cords, and develop lumens that mature into functional vessels. Vasculogenesis is the dominant vascular-formation process during embryonic development, when the primary vascular plexus is laid down de-novo before later remodelling by angiogenic sprouting.
In adult tissue, vasculogenesis is a less prominent contributor to vascular remodelling than angiogenesis, but it has been documented in ischemic-tissue repair contexts where bone-marrow-derived endothelial progenitor cells home to sites of vascular injury, engraft into the damaged tissue, and contribute to neovascular formation alongside the angiogenic sprouting response. The relative contributions of vasculogenesis and angiogenesis to adult-tissue revascularisation remain an active research question, with the integrated process most often described as neovascularisation when the experimental tools cannot cleanly separate the two.
How vasculogenesis is distinguished from angiogenesis in peptide research
The distinction matters because the regulatory inputs, cell-of-origin, and therapeutic implications differ. Angiogenesis is driven primarily by growth-factor signalling on existing endothelium (VEGF, FGF, PDGF and others) and is the dominant target of anti-angiogenic biologics in oncology. Vasculogenesis depends on endothelial-progenitor-cell mobilisation and engraftment, with bone-marrow-niche signalling and circulating-progenitor recruitment as the key regulatory inputs.
For most peptide-research compounds with documented vascular effects, the published mechanism is angiogenic rather than vasculogenic — including the canonical BPC-157 VEGFR2-Akt-eNOS cascade on existing endothelium (PMID 27847966) and the broader blood-vessel literature for the compound (PMID 23782145). The major-vessel-occlusion / collateral-circulation work documents an overlapping arteriogenic / collateral-recruitment phenotype distinct from pure vasculogenesis (PMID 35125818). Distinguishing vasculogenic from angiogenic contribution in an experimental model requires lineage-tracing techniques (genetic labelling of bone-marrow-derived cells, or transplantation studies) that the dominant peptide-research literature does not routinely employ.
Related terms
- Angiogenesis
- VEGFR2
- VEGF
- Endothelial cell
- Endothelial progenitor cell (EPC)
- Arteriogenesis
- Neovascularisation
Compounds where vascular formation appears in the research literature
- BPC-157 — angiogenic findings dominate the published mechanism; vasculogenic contribution is not specifically separated in the literature
- TB-500 — angiogenic and endothelial-migration findings via integrin-linked kinase pathway, with limited literature on endothelial-progenitor-cell engagement
- GHK-Cu — copper-dependent vascular signalling in tissue-repair contexts where angiogenic and vasculogenic contributions are not cleanly separated
References
- Hsieh MJ et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl) 2017;95(3):323-333. [PMID 27847966]
- Seiwerth S et al. BPC 157 and blood vessels. Curr Pharm Des 2014;20(7):1121-1125. [PMID 23782145]
- Sikiric P et al. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances. World J Gastroenterol 2022;28(1):1-22. [PMID 35125818]
Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.